4.7 Article

Differential Effects of the CRF-R1 Antagonist GSK876008 on Fear-Potentiated, Light- and CRF-Enhanced Startle Suggest Preferential Involvement in Sustained vs Phasic Threat Responses

Related references

Note: Only part of the references are listed.
Review Anatomy & Morphology

Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer

David L. Walker et al.

BRAIN STRUCTURE & FUNCTION (2008)

Article Behavioral Sciences

The effects of sex and neonatal maternal separation on fear-potentiated and light-enhanced startle

R de Jongh et al.

BEHAVIOURAL BRAIN RESEARCH (2005)

Article Neurosciences

Anxiogenic treatments do not increase fear-potentiated startle in mice

VB Risbrough et al.

BIOLOGICAL PSYCHIATRY (2005)

Review Pharmacology & Pharmacy

Role of the bed nucleus of the stria tenninalis versus the amygdala in fear, stress, and anxiety

DL Walker et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2003)

Article Neurosciences

Light-enhanced startle: further pharmacological and behavioral characterization

DL Walker et al.

PSYCHOPHARMACOLOGY (2002)

Article Pharmacology & Pharmacy

Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526

T Hikichi et al.

PHARMACOPSYCHIATRY (2000)